EAM Investors’s Cerevel Therapeutics Holdings, Inc. Common Stock CERE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q1
Sell
-39,907
Closed -$1.29M 413
2021
Q4
$1.29M Sell
39,907
-10,411
-21% -$338K 0.21% 237
2021
Q3
$1.48M Sell
50,318
-4,703
-9% -$139K 0.25% 204
2021
Q2
$1.41M Buy
+55,021
New +$1.41M 0.22% 251